The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
about
Role of prostate magnetic resonance imaging in active surveillance.Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population.Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.Targeted Prostate Biopsy in the Era of Active Surveillance.Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT.Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method.Imaging for the selection and monitoring of men on active surveillance for prostate cancer.Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance.Entering an era of radiogenomics in prostate cancer risk stratification
P2860
Q38671172-CCE2A90E-E364-4DAB-8A2C-00214D91B95EQ38924660-35203CD5-B4F4-47F0-BB63-93E28FB5EFB8Q38949882-6B6D7A28-45F0-471C-853C-DB48119D72D5Q38989771-F11AD681-9C4D-4FED-9050-3D289976908EQ39041614-3126F2A4-FE18-4CE8-BDDC-CE06AF196D3EQ39356191-02758738-CE8B-4F9E-9C00-6E5CABFBAF14Q48527660-83445E76-914E-4B00-9E36-3003D34A65A6Q49318705-9774DD3F-316A-406C-A192-43DAD2B17C20Q51733070-4A413276-E719-4548-879F-06F3B3B5AC8FQ52624219-94551EB0-EB1E-4957-9AF0-90F6F7585628Q55129274-EF1D0C48-8B2A-42E5-AC2F-20F388BAC6C1Q55259128-E61D093D-BAC1-4ECF-AFD5-E38A2C702628Q55519803-4E90CD8C-DC7E-4110-A3D9-105C5CC71532Q58562049-5F0555F2-EDCD-4895-BA3C-4AF6FF8C78BD
P2860
The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The Efficacy of Multiparametri ...... Cancer on Active Surveillance.
@en
type
label
The Efficacy of Multiparametri ...... Cancer on Active Surveillance.
@en
prefLabel
The Efficacy of Multiparametri ...... Cancer on Active Surveillance.
@en
P2093
P2860
P1476
The Efficacy of Multiparametri ...... Cancer on Active Surveillance
@en
P2093
Behfar Ehdaie
Daniel D Sjoberg
Daniel Lee
Hebert A Vargas
James A Eastham
Jonathan Coleman
Karim Touijer
Melissa Assel
Vincent P Laudone
P2860
P304
P356
10.1016/J.JURO.2016.02.084
P407
P577
2016-02-23T00:00:00Z